PAR-25-261 - NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases | NOT-DA-22-048 | NIDA, NCI, NIDCR | Jan 9, 2023 | Sep 9, 2025 | R01, R21, DP2, DP1, K99/R00, K01, R36, K08, R15, K24 |
| Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings | NOT-DA-21-060 | NIDA, NIMH | Nov 18, 2021 | Jan 8, 2025 | R34, R01, DP1, DP2 |
| Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience | NOT-DA-21-030 | NIDA | Jun 22, 2021 | Jan 8, 2025 | R01, R21, R03, DP2, DP1, K99/R00, K01, R36, P01, R15, K24 |
For technical issues E-mail OER Webmaster